D1, not D2, dopamine receptor activation dramatically improves MPTP-induced parkinsonism unresponsive to levodopa
Richard B. Mailman, Yang Yang, Xuemei Huang
Topics & Concepts
MPTPParkinsonismDopamine receptor D2LevodopaDopamineDopamine receptorPharmacologyNeuroscienceDopamine receptor D1Dopamine receptor D3ChemistryMedicineParkinson's diseaseDopaminergicInternal medicinePsychologyDiseaseNeurological disorders and treatmentsParkinson's Disease Mechanisms and TreatmentsNeurological and metabolic disorders